FDA Evaluating Cancer Link in Parkinson's Drug
2010/04/01 08:51:54 @FOXNews.com
The U.S. Food and Drug Administration is evaluating clinical data that may suggest Novartis AG's Parkinson's disease treatment Stalevo is linked to an increased risk of prostate cancer. [ VIEW FULL COVERAGE @FOXNews.com ]